Roth Capital Upgrades Celldex Therapeutics to Buy

Loading...
Loading...
Roth Capital has upgraded Celldex Therapeutics
CLDX
to Buy.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesPre-Market OutlookAnalyst RatingsRoth Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...